4//SEC Filing
McCubbin Quentin 4
Accession 0001127602-22-005334
CIK 0001703647other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:04 PM ET
Size
12.7 KB
Accession
0001127602-22-005334
Insider Transaction Report
Form 4
McCubbin Quentin
Chief Manufacturing Officer
Transactions
- Exercise/Conversion
Common Stock
2022-02-14+17,500→ 29,563 total - Sale
Common Stock
2022-02-15$4.33/sh−1,261$5,461→ 28,302 total - Exercise/Conversion
Restricted Stock Unit
2022-02-14−17,500→ 17,500 total→ Common Stock (17,500 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 2063 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2021.
- [F3]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.28 to $4.40. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F5]The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001842009
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:04 PM ET
- Size
- 12.7 KB